$1.93
1.53%
Nasdaq, Sep 24, 04:00 pm EDT. Closed.
ISIN
NL0012661870
Symbol
IFRX

InflaRx N.V. Target price 2026 - Analyst rating & recommendation

InflaRx N.V. Classifications & Recommendation

Buy
86%
Hold
14%

InflaRx N.V. Price Target

Target Price $8.67
Price $1.93
Potential
Number of Estimates 10
10 Analysts have issued a price target InflaRx N.V. 2027 . The average InflaRx N.V. target price is $8.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 12 Analysts recommend InflaRx N.V. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the InflaRx N.V. stock has an average upside potential 2027 of . Most analysts recommend the InflaRx N.V. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.77 -0.32
13.48% 58.44%
P/E negative

9 Analysts have issued a InflaRx N.V. forecast for earnings per share. The average InflaRx N.V. EPS is

$-0.32
unlock
. This is
18.52% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.29 7.41%
unlock
, the lowest is
$-0.36 33.33%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.77 13.48%
2026
$-0.32 58.44%
unlock
2027
$-0.40 25.00%
unlock
2028
$-0.52 30.00%
unlock
2029
$-0.52 0.00%
unlock
2030
$-0.69 32.69%
unlock
2031
$-0.74 7.25%
unlock
2032
$-0.78 5.41%
unlock
2033
$0.08 110.26%
unlock

P/E ratio

Current -7.15 316.10%
2026
-6.09 14.80%
unlock
2027
-4.81 21.02%
unlock
2028
-3.72 22.66%
unlock
2029
-3.72 0.00%
unlock
2030
-2.82 24.19%
unlock
2031
-2.61 7.45%
unlock
2032
-2.47 5.36%
unlock
2033
24.90 1,108.10%
unlock

Current InflaRx N.V. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Needham
Locked
➜
Locked
Locked Sep 14 2026
Cantor Fitzgerald
Locked
➜
Locked
Locked Aug 07 2026
Raymond James
Locked
➜
Locked
Locked May 13 2026
Cantor Fitzgerald
Locked
➜
Locked
Locked May 11 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked May 11 2026
Guggenheim
Locked
➜
Locked
Locked Apr 21 2026
Guggenheim
Locked
➜
Locked
Locked Mar 20 2026
Analyst Rating Date
Locked
Needham:
Locked
➜
Locked
Sep 14 2026
Locked
Cantor Fitzgerald:
Locked
➜
Locked
Aug 07 2026
Locked
Raymond James:
Locked
➜
Locked
May 13 2026
Locked
Cantor Fitzgerald:
Locked
➜
Locked
May 11 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
May 11 2026
Locked
Guggenheim:
Locked
➜
Locked
Apr 21 2026
Locked
Guggenheim:
Locked
➜
Locked
Mar 20 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today